L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
about
L-citrulline provides a novel strategy for treating chronic pulmonary hypertension in newborn infantsArginases and arginine deficiency syndromesIntravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged miceDiabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementationNitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley ratsL-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring CohortRescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.Therapeutic Benefits of l-Arginine: An Umbrella Review of Meta-analyses.An increased need for dietary cysteine in support of glutathione synthesis may underlie the increased risk for mortality associated with low protein intake in the elderlyArginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase PhosphorylationArginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria.The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.L-arginine supplementation reduces cardiac noradrenergic neurotransmission in spontaneously hypertensive rats.l-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Sodium-coupled neutral amino acid transporter 1 (SNAT1) modulates L-citrulline transport and nitric oxide (NO) signaling in piglet pulmonary arterial endothelial cells.Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation.Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.Calcium-activated potassium channels - a therapeutic target for modulating nitric oxide in cardiovascular disease?The effect of nitric-oxide-related supplements on human performance.L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial.The effects of short term L-citrulline supplementation on wave reflection responses to cold exposure with concurrent isometric exercise.L-Citrulline ameliorates chronic hypoxia-induced pulmonary hypertension in newborn piglets.
P2860
Q26829856-4E327530-AA6E-4AF6-8FE0-FD094B5ECD8AQ28396137-26A77601-2970-4E2A-A9E7-859415D12A3AQ28397692-D50F5E40-55BB-413F-A8E8-B1C2DF69BEFAQ34627559-7114A810-1CE8-44C9-A572-635522DFAD32Q34755179-701AE2E8-4741-4536-831F-B02AC9BE78ADQ35093512-138CD448-8CE9-4DCB-97C3-B502CBC7BC3AQ35572566-4217D3E5-BDC5-49A4-9A5B-01BD96E2C528Q36049218-E4075393-FF5F-4D96-B45C-40EC1B2DD567Q36142271-2F8FFD97-597A-449C-A811-6F4A8CDAE637Q37219282-0E79E368-427E-4430-A048-BEFC8F4B2AA5Q37231836-BA92D91F-756D-47E9-94C5-6EF9640B70DCQ37251599-DA3257EB-DE05-4CA2-8265-D897E448110CQ37313734-FEFA561B-9605-40D1-A152-1F3354D07440Q37324756-9CB79424-B285-4814-A87B-BADB6893B50BQ37412089-2B3AFE09-106A-43E7-B888-AFABBC3FE398Q37484397-CA1748CA-9F00-4B33-9D9C-2DB97FC573F8Q37585921-1C5F491C-9559-4B56-B8A1-E43003A97A06Q37615958-27DC5916-D94B-437E-A542-49D4B2D96948Q37766237-33D4A5F4-0B60-4674-9030-0597CAE84657Q37977148-6FB15BED-7457-4B04-8D3A-1D23B1E89656Q38656263-496838E5-9CDD-4759-B766-E0EB0A03F529Q45444073-A1854AA9-1B9B-4FE3-929B-5A3367F2CDD0Q45925606-695F3470-F921-4D08-91D9-195634EDDA11
P2860
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@en
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@nl
type
label
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@en
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@nl
prefLabel
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@en
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@nl
P1476
L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
@en
P2093
Rainer H Böger
P356
10.1097/MCO.0B013E3282F2B0C3
P577
2008-01-01T00:00:00Z